A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.

  title={A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.},
  author={Christopher J. Kratochvil and Brigette S Vaughan and Julie Ann Stoner and Joan M Daughton and Brian D Lubberstedt and Desiree W. Murray and Allan K. Chrisman and Melissa A Faircloth and Nilda B Itchon-Ramos and Scott Haden Kollins and Lawrence A Maayan and Laurence Lee Greenhill and Lisa A Kotler and Jane Fried and John S. March},
  volume={127 4},
OBJECTIVE To evaluate the efficacy and tolerability of atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in 5- and 6-year-old children. METHODS This was an 8-week, double-blind, placebo-controlled randomized clinical trial of atomoxetine in 101 children with ADHD. Atomoxetine or placebo was flexibly titrated to a maximum dose of 1.8 mg/kg per day. The pharmacotherapist reviewed psychoeducational material on ADHD and behavioral-management strategies with parents… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 21 extracted citations


Publications referenced by this paper.
Showing 1-10 of 11 references

Peabody Picture Vocabulary Test , 3 rd Edition , Form IIIA and Form IIIB

  • LM Dunn
  • Circle Pines , MN : American Guidance Service
  • 1997

Sequentialmonitoring of clinical trials with correlated responses

  • SJ Gange, DL DeMets
  • Biometrika
  • 1996

Group sequential methods in the design and analysis of clinical trials

  • SJ Pocock
  • 1977

Similar Papers

Loading similar papers…